NCT06924502 Testing the Protective and Caring Effect of a Water-in-oil Formulation in Patients Suffering From Urinary and/or Fecal Incontinence and Requiring Incontinence Care Products
| NCT ID | NCT06924502 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Dr. August Wolff GmbH & Co. KG Arzneimittel |
| Condition | Incontinence, Urinary |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-06-06 |
| Primary Completion | 2025-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-06-06 with a primary completion date of 2025-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to test the protecting and caring effect of a protective balm on patients suffering from urinary and/or fecal incontinence and need incontinence care products.
Eligibility Criteria
Inclusion Criteria: * Patient is capable of understanding the information given to them and providing informed consent * 70 years of age and older * Patients with incontinence (fecal and/or urinary), requiring incontinence protection material * Skin type on Fitzpatrick scale: Between I to IV Exclusion Criteria: * Current cancer treatment such as chemotherapy, irradiation * Documented allergies to skin care and / or skin cleansing products * Wounds, moles, tattoos, scars, irritated skin, excessive hair growth, etc. at the test area that could influence the investigation * Incontinence-associated dermatitis (IAD) stage \>1a * Active skin disease at the test area * Any topical medication at the test area within the last 3 days prior to the start of the study and / or hroughout te entire course of the study * Mini-Mental-Status-Test (MMST) \< 20
Contact & Investigator
Clarissa Masur
✉ clarissa.masur@drwolffgroup.comFrequently Asked Questions
Who can join the NCT06924502 clinical trial?
This trial is open to participants of all sexes, aged 70 Years or older, studying Incontinence, Urinary. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06924502 currently recruiting?
Yes, NCT06924502 is actively recruiting participants. Contact the research team at clarissa.masur@drwolffgroup.com for enrollment information.
Where is the NCT06924502 trial being conducted?
This trial is being conducted at Dortmund, Germany.
Who is sponsoring the NCT06924502 clinical trial?
NCT06924502 is sponsored by Dr. August Wolff GmbH & Co. KG Arzneimittel. The trial plans to enroll 40 participants.